These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 8664520

  • 1. Renal retransplants: effect of primary allograft nephrectomy on early function, acute rejection and outcome.
    Douzdjian V, Rice JC, Carson RW, Gugliuzza KK, Fish JC.
    Clin Transplant; 1996 Apr; 10(2):203-8. PubMed ID: 8664520
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Graft outcome in cadaver renal transplants treated with full-dose cyclosporine induction without antibody, irrespective of graft function.
    Douzdjian V, Bhaskar S, Baliga PK, Rajagopalan PR.
    Clin Transplant; 1997 Aug; 11(4):294-8. PubMed ID: 9267718
    [Abstract] [Full Text] [Related]

  • 5. Kidney retransplantation in the cyclosporine era.
    Stratta RJ, Oh CS, Sollinger HW, Pirsch JD, Kalayoglu M, Belzer FO.
    Transplantation; 1988 Jan; 45(1):40-5. PubMed ID: 3276060
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A.
    Acta Med Port; 2004 Jan; 17(1):8-14. PubMed ID: 15636737
    [Abstract] [Full Text] [Related]

  • 10. Risk factors affecting second renal transplant outcome, with special reference to primary allograft nephrectomy.
    Abouljoud MS, Deierhoi MH, Hudson SL, Diethelm AG.
    Transplantation; 1995 Jul 27; 60(2):138-44. PubMed ID: 7624955
    [Abstract] [Full Text] [Related]

  • 11. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
    Thervet E, Pfeffer P, Scolari MP, Toselli L, Pallardó LM, Chadban S, Pilmore H, Connolly J, Buchler M, Schena FP, Carreño CA, Dandavino R, Cole E.
    Transplantation; 2003 Sep 27; 76(6):903-8. PubMed ID: 14508352
    [Abstract] [Full Text] [Related]

  • 12. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA, Lehman AM, Nadasdy GM, Sedmak DD, Pesavento TE, Henry ML, Pelletier RP, Ferguson RM, Nadasdy T.
    Clin Transplant; 2008 Sep 27; 22(1):61-7. PubMed ID: 18217907
    [Abstract] [Full Text] [Related]

  • 13. Intermediate-term outcome of renal retransplants in the cyclosporine era.
    Sumrani NB, Miles AM, Daskalakis P, Hong JH, Markell MS, Friedman EA, Sommer BG.
    ASAIO J; 1993 Sep 27; 39(1):47-50. PubMed ID: 8439680
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May 27; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 15. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H, Haussman G, Isaacs I, Ishitani M, Lobo P, McCullough C, Pruett T.
    Clin Transplant; 1997 Oct 27; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [Abstract] [Full Text] [Related]

  • 16. The influence of nephrectomy of the primary allograft on retransplant graft outcome in the cyclosporine era.
    Sumrani N, Delaney V, Hong JH, Daskalakis P, Sommer BG.
    Transplantation; 1992 Jan 27; 53(1):52-5. PubMed ID: 1733085
    [Abstract] [Full Text] [Related]

  • 17. Acute rejection and late renal transplant failure: risk factors and prognosis.
    Pallardó Mateu LM, Sancho Calabuig A, Capdevila Plaza L, Franco Esteve A.
    Nephrol Dial Transplant; 2004 Jun 27; 19 Suppl 3():iii38-42. PubMed ID: 15192134
    [Abstract] [Full Text] [Related]

  • 18. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group.
    Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398
    [Abstract] [Full Text] [Related]

  • 19. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids.
    Cantarovich D.
    J Nephrol; 2004 Nov 15; 17 Suppl 8():S40-6. PubMed ID: 15599885
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.